3663-35-2

Basic information

• Product Name: 4-ethyl-2-nitro-aniline
• Synonyms: 4-ethyl-2-nitro-aniline
• CAS NO: 3663-35-2
• Molecular Formula: C₈H₁₀N₂O₂
• Molecular Weight: 166.18
• Mol File: 3663-35-2.mol

Chemical Properties

• Melting Point: 45-47 °C
• Boiling Point: 314°Cat760mmHg
• Flash Point: 143.7°C
• Appearance: /
• Density: 1.218g/cm³
• Vapor Pressure: 0.000479mmHg at 25°C
• Refractive Index: 1.598
• PKA: 0.45±0.10(Predicted)
• CAS DataBase Reference: 4-ethyl-2-nitro-aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-ethyl-2-nitro-aniline(3663-35-2)
• EPA Substance Registry System: 4-ethyl-2-nitro-aniline(3663-35-2)

Safety Data

• Hazardous Substances Data: 3663-35-2(Hazardous Substances Data)

Usage

Uses

Used in Dye and Pigment Production:
4-ethyl-2-nitro-aniline is used as a key intermediate in the synthesis of various dyes and pigments. Its unique chemical structure allows for the creation of a wide range of colors, making it valuable in the production of textiles, paints, and other color-intensive products.
Used in Organic Synthesis:
In the field of organic synthesis, 4-ethyl-2-nitro-aniline serves as a versatile building block for the development of new compounds. Its presence of both nitro and amine groups enables a variety of chemical reactions, contributing to the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Research and Development:
4-ethyl-2-nitro-aniline is also utilized in research and development settings, where its unique properties are explored for potential applications in new technologies and materials. Its reactivity and structural characteristics make it a valuable compound for scientific investigations and the advancement of chemical knowledge.

InChI:InChI=1/C8H10N2O2/c1-2-6-3-4-7(9)8(5-6)10(11)12/h3-5H,2,9H2,1H3

Upstream product

• 1585-07-5 1-bromo-4-ethylbenzene 
• 50321-08-9 (4-ethyl-2-nitro-phenyl)-carbamic acid ethyl ester 
• 3663-34-1 N-(4-ethylphenyl)acetamide 
• 123-91-1 1,4-dioxane 
• 589-16-2 4-aminoethylbenzene 
• 3663-33-0 acetic acid-(4-ethyl-2-nitro-anilide) 

Downstream Products

• 96548-20-8 α-chloro-β-(4-ethyl-2-nitrophenyl)propionic acid 
• 848589-59-3 2-[3-(4-ethyl-2-nitro-phenylamino)-propyl]-isoindole-1,3-dione 
• 109097-05-4 1-(4-ethyl-2-nitro-anilino)-D-1-deoxy-ribitol 
• 123158-65-6 2-bromo-4-ethyl-6-nitroaniline 
• 123158-72-5 6-chloro-4-ethyl-2-nitroaniline 
• 116599-06-5 4-ethyl-o-phenylenediamine; dihydrochloride 
• 1261225-72-2 4-ethyl-2-iodo-6-nitroaniline 
• 1261225-73-3 1-ethyl-3-iodo-5-nitrobenzene 
• 1261225-74-4 3-ethyl-5-iodoaniline 
• 123158-73-6 3-Chloro-5-ethylnitrobenzene 
• 123158-66-7 3-bromo-5-ethyl-nitrobenzene 
• 123158-68-9 3-bromo-5-ethylaniline 
• 72572-18-0 6-ethylbenzimidazole 
• 1095636-39-7 1,2-dibromo-5-ethyl-3-nitrobenzene 

Relevant articles and documents

Discovery of Novel Indole Derivatives as Fructose-1,6-bisphosphatase Inhibitors and X-ray Cocrystal Structures Analysis

Liver fructose-1,6-bisphosphatase (FBPase) is a key enzyme in the gluconeogenesis, and its inhibitors are expected to be novel antidiabetic agents. Herein, a series of new indole and benzofuran analogues were designed and synthesized to evaluate the inhib

SULFONYL-SUBSTITUTED BICYCLIC COMPOUND WHICH ACTS AS ROR INHIBITOR

Provided is a sulfonyl-substituted bicyclic compound (A) which acts as a RORγ inhibitor, said compound has good RORγ inhibitory activity and is expected to be used for treating diseases mediated by a RORγ receptor in mammals.

Next Generation of Guanidine Quinoline Copper Complexes for Highly Controlled ATRP: Influence of Backbone Substitution on Redox Chemistry and Solubility

Ligands DMEG6etqu, TMG6etqu, DMEG6buqu, and TMG6buqu were developed on the basis of guanidine quinoline (GUAqu) ligands 1,3-dimethyl-N-(quinolin-8-yl)imidazolidin-2-imine (DMEGqu) and 1,1,3,3-tetramethyl-2-(quinolin-8-yl)guanidine (TMGqu). These ligands feature an alkyl substituent at the C6 of the quinoline backbone. The synthetic strategy developed here enables inexpensive syntheses of any kind of C6-substituted GUAqu ligands. On one hand, the alkylation increases the solubility of corresponding copper complexes in apolar atom transfer radical polymerization (ATRP) monomers like styrene. On the other hand, it has a significant electronic influence and thus an effect on the donor properties of the new ligands. Seven CuI and CuII complexes of DMEG6etqu and TMG6etqu have been crystallized and were studied with regard to their structural and electrochemical properties. CuI and CuII complexes of DMEG6buqu and TMG6buqu turned out to be perfectly soluble in pure styrene even at room temperature, which makes them excellent catalysts in the ATRP of apolar monomers. The key characteristics of the ATRP equilibrium, KATRP and kact, were determined for the new complexes. In addition, we used our recently developed DFT methodology, NBO analysis, and isodesmic reactions to predict the influence of the introduced alkyl substituents. It turned out that high conformational freedom in the complex structures leads to a significant uncertainty in prediction of the thermodynamic properties.

PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONISTS

Cyclohexyl sulfonamide compounds which are platelet-activating factor (PAF) receptor antagonists. Said compounds may be useful, for example, for the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders.

Concise total synthesis of

An efficient nine-step total synthesis of the annulated indole natural products.

Heterocyclic compounds as inhibitors of factor VIIa

The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel heterocyclic compounds, or a stereoisomer or pharmaceutically acceptable salt, solvate, or prodrug form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.

Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders

4-Oxo-1,4-dihydroquinoline compounds having a 2-acidic group or a group convertible thereto in vivo, and their pharmaceutically acceptable salts, are potent specific antagonists of N-methyl-D-aspartate (NMDA) receptors and are therefore useful in the treatment of neurodegenerative disorders. 4-Oxo-1,4-dihydroquinoline compounds having a 2-acidic group or a group convertible thereto in vivo, other than carboxy or C 1-6 alkoxycarbonyl, are novel compounds, as also are compounds of formula II STR1 wherein R 2 represents carboxy or a group convertible thereto in vivo, R 6 is hydrogen and R 5 and R 7 represent C 1-6 alkyl or halogen, provided that R 5 and R 7 are not simultaneously chlorine or simultaneously bromine; a process for preparing the novel compounds is described, as also are pharmaceutical compositions containing the novel compounds.

2-(4-pyridylaminomethyl)-benzimidazole derivatives having antiviral activity

Provided herein is an antiviral 2-(4-pyridylaminomethyl)-benzimidazole of the formula: STR1 wherein R is a radical selected from the groups consisting of hydrogen, short-chain alkyl, short-chain alkoxy, benzoyl, halogenomethyl, halogen, nitro and amino groups; the preparation of these compounds and antiviral composition containing such compounds.

Process for the production of 2-aryl-2H-benzotriazoles

A process for the production of 2-aryl-2H-benzotriazoles comprises reducing and cyclizing the corresponding o-nitroazobenzenes with hydrogen at a temperature in the range of about 20° C. to about 100° C. and at a pressure in the range of about 15 psia (1 atmosphere) to about 1000 psia (66 atmospheres) in an alkaline medium at a pH over 10 in the presence of a nickel catalyst, preferably molybdenum-promoted Raney nickel. High yields of pure product are obtained directly with a concomitant reduction of undesired by-product and a reduction in effluent pollution problems.

Process for the production of 2-aryl-2H-benzotriazoles

A process for the production of 2-aryl-2H-benzotriazoles comprises reducing and cyclizing the corresponding o-nitroazobenzenes with hydrogen at a temperature in the range of about 20° C. to about 100° C. and at a pressure in the range of about 15 psia (1 atmosphere) to about 1000 psia (66 atmospheres) in an organic solvent mixture containing an organic amine at a pH over 10 in the presence of noble metal hydrogenation catalyst, preferably palladium. High yields of pure product are obtained with a concomitant reduction of undesired by-products and a reduction in effluent pollution problems.